Utilization Management, Purpose Built for Oncology
Oncology Analytics provides health plans with an evidence-based, technologically driven approach to utilization management, which is purpose-built for oncology.
Used by physicians to support over 2.5 million health plan members in the US and Puerto Rico, the Oncology Analytics e-Prior Authorization platform is updated daily to accurately reflect more than 6,000 oncology treatment protocols for anti-cancer treatment across all cancer types and stages, including chemotherapy, radiation therapy, precision medicine, targeted therapy and supportive care.
Our board-certified oncologists, radiation oncologists, hematologists, and pharmacists have operationalized protocols that cover all cancer diagnoses, and provide insights and analytics that health plans and providers can leverage to further innovation and improvement in cancer care.
Solutions
Utilization Management, Purpose Built for Oncology
e-Prior Authorization
Oncology Analytics e-Prior Authorization platform, is purpose built for oncology to efficiently evaluate and approve high-quality and high-value treatments for cancer care.
Read More
Specialty Oncology Case Review
For complex and complicated patient cases, peer-to-peer reviews are facilitated by our Clinical Team, which may include in depth reviews by our Distinguished Academic Advisory Board.
Read More
Cancer Care Insights & Analytics
Oncology Analytics offers deep insights and analytics for health plans and providers, which can aid in the further development and improvement of cancer care.
Read More
Oncology Analytics is a strong advocate for the patient and for appropriate health care expenditure. The company is founded on the most ethical of principles and interacts with treating physicians in a collegial manner. I wholeheartedly support their mission and their methods.
John Lister, MD, Chief of Hematology & Oncology, Western Pennsylvania Hospital
News
Oncology Analytics appoints Rick Dean as Chief Executive Officer
Oncology Analytics, a comprehensive oncology benefits management and analytics company serving health plans, providers and patients in the United States and Puerto Rico announced today that its Board of Directors has appointed Rick Dean as Chief Executive Officer...
read moreOncology Analytics, Inc. Launches Comprehensive User-Friendly Clinical Decision Support Tool for Molecular & Genetic Testing
In response to the thousands of genetic and molecular tests being marketed, which consequently inundate health plans with reimbursement and policy coverage decisions, Oncology Analytics, Inc. has launched a clinical decision support tool for molecular and genetic...
read moreOncology Analytics Reports 99% Adherence to Evidence-Based Treatment Protocols Based on 50,000 Cases
Oncology Analytics, Inc. reports today that an analysis of a years’ worth of its chemotherapy protocol data totaling more than 50,000 approved oncology cases ending June 2017 indicates that 98.64% of approved protocols were supported by a high level of scientific...
read moreEvents
AHIP Institute and Expo 2018
June 20 – 22, 2018
San Diego Convention Center
San Diego, CA
Booth #731